The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG's annual profit falls as acquisitions and foreign exchange movements offset revenue growth

Tue, 19th May 2015 10:49

Healthcare company BTG reported a drop in pre-tax annual profit, reflecting investments, acquisitions and foreign exchange movements.Pre-tax profit came to £26.7m, down from £33.3m the previous year, the group said.Revenue rose 27% to £367.8m from £290.5m a year earlier, as each division delivered strong double-digit percentage growth. Recurring Interventional Medicine revenue grew 44% to £112.7m, revenue in Specialty Pharmaceuticals increased 18% to £121.1m and Licensing revenues jumped 23% to £134m.When adjusting for constant currency and the impact of acquisitions of EKOS and TheraSphere, like-for-like revenue growth was 21%.Adjusted earnings per share was up 8% to 15.7p."We have delivered a good financial performance for the year, with each business delivering underlying growth of more than 20%," said chief executive Louise Makin."We look forward to another year of strong progress, confident that the strategy we are following will over time enable us to become a world leader in Interventional Medicine therapies and deliver significant value for all our stakeholders."
More News
8 Jun 2016 13:18

Wednesday broker round-up

(ShareCast News) - Hochschild Mining: UBS downgrades to neutral with a target price of 160p. Esure Group: JP Morgan keeps at overweight with a 330p target. Royal Dutch Shell: RBC reiterates outperform with a target price of 2000p and JP Morgan stays atneutral with a target price of 1630p. National

Read more
19 May 2016 08:30

BROKER RATINGS SUMMARY: Goldman Sachs Upgrades BT To Conviction Buy

Read more
18 May 2016 08:31

BROKER RATINGS SUMMARY: Goldman Upgrades Booker, Panmure Cuts Meggitt

Read more
17 May 2016 09:40

WINNERS & LOSERS SUMMARY: Taylor Wimpey Pleases With Payout Plan

Read more
17 May 2016 07:56

Revenue jump boosts BTG full-year profits

(ShareCast News) - Healthcare company BTG more than doubled full year pre-tax profits to £57.5m on the back of a 22% jump in revenues to £447.5m. The company said expected revenue for fiscal 2017 to be in the range of £485m-£515m, with selling general and administrative costs to be £160m-£170m and r

Read more
17 May 2016 06:57

TOP NEWS: BTG Doubles Annual Profit On Significant Revenue Rise

Read more
10 May 2016 15:10

Earnings, Trading Statements Calendar - Week Ahead

Read more
6 May 2016 09:23

BTG buys Galil Medical for inital £58.3

(ShareCast News) - Specialist healthcare company BTG said it was buying Galil Medical, a leading provider of cryoablation products for the treatment and palliative care of kidney and other cancers, for an initial £58.3m. BTG said it would also pay up to £17.6m in future regulatory and commercial mil

Read more
6 May 2016 08:10

BTG Acquires US-Based Cryoablation Systems Maker Galil Medical

Read more
5 Apr 2016 07:41

BTG exudes confidence ahead of final reuslts

(ShareCast News) - Specialist healthcare company BTG was confident ahead of its final results on Tuesday, claiming reported group revenue for the year to 31 March was expected to be at the upper end of its guidance range of £410m-£440m, boosted by currency tailwinds. The growth at the FTSE 250 compa

Read more
5 Apr 2016 06:39

BTG Revenue To Hit Upper End Of Guidance Amid Solid Sales Growth

Read more
4 Apr 2016 05:23

BTG To Initiate Target Study To Evaluate Dosimetry For HCC Patients

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
15 Dec 2015 17:05

LONDON MARKET CLOSE: Oil Recovers As US Inflation Supports Fed Hike

Read more
15 Dec 2015 15:24

FTSE 250 movers: Broker notes spur on big movers

(ShareCast News) - The FTSE 250 looks to finish the day in the green, with the second-tier market up 228.85 point (1.36%) to 17,001.42 mid-afternoon Tuesday. Circassia Pharmaceuticals rose to the top of the ranks after RBC Capital Markets initiated coverage at 'top pick' for the company. "With intr

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.